Zolpidem self-injection with concurrent physical dependence under conditions of long-term continuous availability in baboons
- PMID: 9832941
Zolpidem self-injection with concurrent physical dependence under conditions of long-term continuous availability in baboons
Abstract
Intravenous zolpidem self-injection, and the concurrent development of physical dependence under conditions of continuous drug availability, was characterized in three baboons. Previously, under similar conditions, 1.0 mg/kg midazolam maintained low, but stable, daily rates of self-injection (e.g. less than 20 injections/day) over 30 or more days and resulted in the development of physical dependence in baboons. In the current experiments, saline and zolpidem (1.0 mg/kg) were available for self-injection under a fixed-ratio (FR-30) schedule of lever-pull responses with a 5 min time-out after each injection. Saline maintained only low levels of responding (i.e. less than five injections per day). Zolpidem maintained an orderly spaced within-day pattern of injections and daily rates of self-injection were higher than saline (i.e. 10 or more injections per day). Daily rates of zolpidem self-injection were relatively stable in two baboons, and increased over time in the third baboon. Substitution of saline for zolpidem produced a rapid decrease in responding that remained low (i.e. less than five injections per day) in all three baboons. Chronic self-injection of zolpidem produced an increase in responding maintained by food pellet delivery and an increase in body weights. Administration of flumazenil (0.1-1.0 mg/kg, i.v.) after at least 35 days of zolpidem self-injection produced postures and behavioral signs typical of a classic flumazenil-precipitated benzodiazepine withdrawal syndrome. Substitution of saline after chronic zolpidem self-injection produced a time-limited spontaneous withdrawal syndrome. Behavioral signs and postures were similar to those observed during flumazenil-precipitated withdrawal and were most prominent during the first 8 days after zolpidem was discontinued. Therefore, like midazolam, zolpidem maintained self-injection and physical dependence developed under conditions of long-term continuous availability.
Similar articles
-
Zolpidem physical dependence assessed across increasing doses under a once-daily dosing regimen in baboons.J Pharmacol Exp Ther. 1998 Apr;285(1):41-53. J Pharmacol Exp Ther. 1998. PMID: 9535993
-
Zolpidem behavioral pharmacology in baboons: self-injection, discrimination, tolerance and withdrawal.J Pharmacol Exp Ther. 1992 Mar;260(3):1199-208. J Pharmacol Exp Ther. 1992. PMID: 1312162
-
Physical dependence in baboons chronically treated with low and high doses of diazepam.Behav Pharmacol. 2003 Jul;14(4):331-42. doi: 10.1097/01.fbp.0000082131.08343.0e. Behav Pharmacol. 2003. PMID: 12838039
-
Reversal of conscious sedation by flumazenil: current status and future prospects.Acta Anaesthesiol Scand Suppl. 1995;108:35-42. Acta Anaesthesiol Scand Suppl. 1995. PMID: 8693923 Review.
-
Epidemiological evidence for a low abuse potential of zolpidem.Pharmacopsychiatry. 2000 Jul;33(4):138-41. doi: 10.1055/s-2000-11224. Pharmacopsychiatry. 2000. PMID: 10958262 Review.
Cited by
-
The effects of repeated zolpidem treatment on tolerance, withdrawal-like symptoms, and GABAA receptor mRNAs profile expression in mice: comparison with diazepam.Psychopharmacology (Berl). 2014 Aug;231(15):2967-79. doi: 10.1007/s00213-014-3473-x. Epub 2014 Feb 15. Psychopharmacology (Berl). 2014. PMID: 24531568
-
The behavioral pharmacology of zolpidem: evidence for the functional significance of α1-containing GABA(A) receptors.Psychopharmacology (Berl). 2014 May;231(9):1865-96. doi: 10.1007/s00213-014-3457-x. Epub 2014 Feb 22. Psychopharmacology (Berl). 2014. PMID: 24563183 Review.
-
Self-administration of gamma-hydroxybutyric acid (GHB) precursors gamma-butyrolactone (GBL) and 1,4-butanediol (1,4-BD) in baboons.Psychopharmacology (Berl). 2013 Feb;225(3):637-46. doi: 10.1007/s00213-012-2851-5. Epub 2012 Sep 4. Psychopharmacology (Berl). 2013. PMID: 22945514 Free PMC article.
-
Zolpidem: an update of its pharmacology, therapeutic efficacy and tolerability in the treatment of insomnia.Drugs. 2000 Apr;59(4):865-89. doi: 10.2165/00003495-200059040-00014. Drugs. 2000. PMID: 10804040 Review.
-
Role of gamma-aminobutyric acid type A (GABAA) receptor subtypes in acute benzodiazepine physical dependence-like effects: evidence from squirrel monkeys responding under a schedule of food presentation.Psychopharmacology (Berl). 2013 May;227(2):347-54. doi: 10.1007/s00213-013-2975-2. Epub 2013 Jan 26. Psychopharmacology (Berl). 2013. PMID: 23354533 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical